<DOC>
	<DOCNO>NCT01321567</DOCNO>
	<brief_summary>To investigate efficacy safety PARIET twice daily ( b.i.d . ) patient Proton Pump Inhibitor-resistant reflux esophagitis</brief_summary>
	<brief_title>Quality Life New Treatable Therapy Rabeprazole Option Refractory Reflux Esophagitis</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Esophagitis , Peptic</mesh_term>
	<mesh_term>Rabeprazole</mesh_term>
	<criteria>Inclusion criterion ; Proton pump inhibitorresistant reflux esophagitis . ( Patients mucosal break ( erosion , ulcer ) endoscopy ) Exclusion criterion ; Patients history hypersensitivity ingredient PARIET . Patients atazanavir sulfate .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>rabeprazole sodium</keyword>
	<keyword>refractory reflux esophagitis</keyword>
</DOC>